SHORTened Duration of TAMoxifen | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SHORTened Duration of TAMoxifen | stella

Back to High Risk for Invasive Breast Cancer trials

Active, not recruiting

Plain-English translation of NCT07806630 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Rutgers Cancer Institute, New Brunswick, New Jersey

Key details

Phase

Testing effectiveness

Sponsor

Rutgers, The State University of New Jersey

Enrollment target

~250 participants

Started

September 2026

Primary completion

July 2028

Age range

30 Years and older

Last updated on clinicaltrials.gov in September 2026.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.